sk&f 7172-a2 has been researched along with w 7 in 1 studies
Studies (sk&f 7172-a2) | Trials (sk&f 7172-a2) | Recent Studies (post-2010) (sk&f 7172-a2) | Studies (w 7) | Trials (w 7) | Recent Studies (post-2010) (w 7) |
---|---|---|---|---|---|
17 | 0 | 0 | 1,197 | 0 | 85 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekokoski, E; Törnquist, K | 1 |
1 other study(ies) available for sk&f 7172-a2 and w 7
Article | Year |
---|---|
Inhibition of agonist-mediated calcium entry by calmodulin antagonists and by the Ca2+/calmodulin kinase II inhibitor KN-62. Studies with thyroid FRTL-5 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Animals; Barium; Biological Transport; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calcium-Transporting ATPases; Calmodulin; Cell Line; Depression, Chemical; Fluphenazine; Imidazoles; Isoquinolines; Membrane Potentials; Phenoxybenzamine; Piperazines; Rats; Sulfonamides; Terpenes; Thapsigargin; Thyroid Gland | 1996 |